Navigating new territory in targeted oncology

Ikena® is redefining the targeted oncology landscape and envisions a world in which every cancer patient has a cure.
Scroll Down

The Ikena Approach

We develop differentiated targeted oncology therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Our ever-growing depth of institutional knowledge and breadth of tools enable us to efficiently develop the right drug using the right modality for the right patient.

Our Pipeline

We are advancing a focused pipeline of novel biomarker-driven targeted cancer therapies. Our programs are built on robust translational research and are optimized for specific patient populations with high unmet needs.

Contact us

Interested in learning more about Ikena?

Scroll to Top